BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11532042)

  • 1. Plurihormonal pituitary adenomas: immunostaining of all pituitary hormones is mandatory for correct classification.
    Ho DM; Hsu CY; Ting LT; Chiang H
    Histopathology; 2001 Sep; 39(3):310-9. PubMed ID: 11532042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of somatostatin receptor subtypes in human pituitary adenomas -- immunohistochemical studies.
    Pisarek H; Pawlikowski M; Kunert-Radek J; Radek M
    Endokrynol Pol; 2009; 60(4):240-51. PubMed ID: 19753537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plurihormonality of pituitary adenomas in light of immunohistochemical studies.
    Pawlikowski M; Kunert-Radek J; Radek M
    Endokrynol Pol; 2010; 61(1):63-6. PubMed ID: 20205106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data.
    Buurman H; Saeger W
    Eur J Endocrinol; 2006 May; 154(5):753-8. PubMed ID: 16645024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of additional transcription factors is of prognostic value for aggressive behavior of pituitary adenomas.
    Micko A; Rötzer T; Hoftberger R; Vila G; Oberndorfer J; Frischer JM; Knosp E; Wolfsberger S
    J Neurosurg; 2020 Apr; 134(3):1139-1146. PubMed ID: 32302984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pituitary tumors: hormonal status and immunohistochemical evaluation].
    Gołkowski F; Trofimiuk M; Buziak-Bereza M; Czepko R; Adamek D; Huszno B
    Przegl Lek; 2003; 60(5):338-41. PubMed ID: 14593675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical and ultrastructural study of plurihormonal pituitary adenomas].
    Liu DG
    Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):223-5, 254. PubMed ID: 8395317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone markers in pituitary adenomas: changes within last decade resulting from improved method.
    Saeger W; Wilczak W; Lüdecke DK; Buchfelder M; Fahlbusch R
    Endocr Pathol; 2003; 14(1):49-54. PubMed ID: 12746562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plurihormonal pituitary macroadenoma:  a case report.
    Allehaibi E; AlMalki MH; Brema I
    J Med Case Rep; 2021 Jul; 15(1):407. PubMed ID: 34321093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double pituitary adenomas: six surgical cases.
    Sano T; Horiguchi H; Xu B; Li C; Hino A; Sakaki M; Kannuki S; Yamada S
    Pituitary; 1999 May; 1(3-4):243-50. PubMed ID: 11081204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
    Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
    Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical detection of estrogen receptor alpha in pituitary adenomas and its correlation with cellular replication.
    Pereira-Lima JF; Marroni CP; Pizarro CB; Barbosa-Coutinho LM; Ferreira NP; Oliveira MC
    Neuroendocrinology; 2004 Mar; 79(3):119-24. PubMed ID: 15103224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional classification of pituitary adenomas.
    Scanarini M; Mingrino S
    Acta Neurochir (Wien); 1980; 52(3-4):195-202. PubMed ID: 7424602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plurihormonal pituitary adenomas.
    Scheithauer BW; Horvath E; Kovacs K; Laws ER; Randall RV; Ryan N
    Semin Diagn Pathol; 1986 Feb; 3(1):69-82. PubMed ID: 3039632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.
    Rishi A; Sharma MC; Sarkar C; Jain D; Singh M; Mahapatra AK; Mehta VS; Das TK
    Neurol India; 2010; 58(3):418-23. PubMed ID: 20644271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of function and proliferation in non-invasive and invasive bi- and plurihormonal adenomas of patients with acromegaly: an immunohistochemical study.
    Müller W; Saeger W; Wellhausen L; Derwahl KM; Hamacher C; Lüdecke DK
    Pathol Res Pract; 1999; 195(9):595-603. PubMed ID: 10507079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The characteristics of incidental pituitary microadenomas in 120 Korean forensic autopsy cases.
    Kim JH; Seo JS; Lee BW; Lee SY; Jeon SH; Lee KB
    J Korean Med Sci; 2007 Sep; 22 Suppl(Suppl):S61-5. PubMed ID: 17923757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional examination versus immunohistochemistry in the prediction of hormone profile of pituitary adenomas. An analysis on 142 cases.
    Bălinişteanu B; Ceauşu RA; Cîmpean AM; Baciu I; Băculescu N; Coculescu M; Raica M
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1041-5. PubMed ID: 22119822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
    Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.